dexamethasone 21-phosphate has been researched along with Lymphoma, Mantle-Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bailey, HH; Blank, J; Bottner, W; Eickhoff, JC; Jones, C; Kahl, BS; Longo, WL; McFarland, T; Rezazedeh, H; Werndli, J; Zehnder, J | 1 |
1 trial(s) available for dexamethasone 21-phosphate and Lymphoma, Mantle-Cell
| Article | Year |
|---|---|
Maintenance rituximab following induction chemoimmunotherapy may prolong progression-free survival in mantle cell lymphoma: a pilot study from the Wisconsin Oncology Network.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Lymphoma, Mantle-Cell; Male; Middle Aged; Pilot Projects; Remission Induction; Rituximab; Survival Analysis; Treatment Outcome; Vincristine | 2006 |